{"id":"https://openalex.org/W7225164722","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","title":"270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor\u2013refractory colorectal cancer liver metastases","display_name":"270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor\u2013refractory colorectal cancer liver metastases","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225164722","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0270"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0270","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A304.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A304.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108963068","display_name":"Shanmugarajan Krishnan","orcid":"https://orcid.org/0009-0001-1013-6134","observed_orcids":["https://orcid.org/0009-0001-1013-6134","https://orcid.org/0000-0003-2593-8348"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shanmugarajan Krishnan","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102729927","display_name":"Bishnu P. Joshi","orcid":"https://orcid.org/0000-0001-8829-5306","observed_orcids":["https://orcid.org/0000-0001-8829-5306"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bishnu Joshi","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005528074","display_name":"Justin G. Keith","orcid":"https://orcid.org/0009-0008-2130-2186","observed_orcids":["https://orcid.org/0009-0008-2130-2186"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin G Keith","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018302338","display_name":"Olivier Le Tonqu\u00e8ze","orcid":"https://orcid.org/0000-0002-4943-3566","observed_orcids":["https://orcid.org/0000-0002-4943-3566"]},"institutions":[{"id":"https://openalex.org/I4405265386","display_name":"MiNK Therapeutics (United States)","ror":"https://ror.org/04n7wdr86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265386"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivier Le Tonqueze","raw_affiliation_strings":["MiNK Therapeutics, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MiNK Therapeutics, Lexington, MA, USA","institution_ids":["https://openalex.org/I4405265386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005178144","display_name":"Reed Masakayan","orcid":"https://orcid.org/0000-0003-3591-8869","observed_orcids":["https://orcid.org/0000-0003-3591-8869"]},"institutions":[{"id":"https://openalex.org/I4405265386","display_name":"MiNK Therapeutics (United States)","ror":"https://ror.org/04n7wdr86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265386"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reed Masakayan","raw_affiliation_strings":["MiNK Therapeutics, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MiNK Therapeutics, Lexington, MA, USA","institution_ids":["https://openalex.org/I4405265386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094222518","display_name":"Nick Kushner","orcid":"https://orcid.org/0009-0000-4930-7351","observed_orcids":["https://orcid.org/0009-0000-4930-7351"]},"institutions":[{"id":"https://openalex.org/I4405265386","display_name":"MiNK Therapeutics (United States)","ror":"https://ror.org/04n7wdr86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265386"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Kushner","raw_affiliation_strings":["MiNK Therapeutics, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MiNK Therapeutics, Lexington, MA, USA","institution_ids":["https://openalex.org/I4405265386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160570011","display_name":"John Chamberland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Chamberland","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075439663","display_name":"Benjamin M. Morin","orcid":"https://orcid.org/0000-0001-6632-0320","observed_orcids":["https://orcid.org/0000-0001-6632-0320"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Morin","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081599526","display_name":"Nils-Petter Rudqvist","orcid":"https://orcid.org/0000-0002-9720-3124","observed_orcids":["https://orcid.org/0000-0002-9720-3124"]},"institutions":[{"id":"https://openalex.org/I4405265386","display_name":"MiNK Therapeutics (United States)","ror":"https://ror.org/04n7wdr86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265386"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nils-Petter Rudqvist","raw_affiliation_strings":["MiNK Therapeutics, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MiNK Therapeutics, Lexington, MA, USA","institution_ids":["https://openalex.org/I4405265386"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110271136","display_name":"Robert Benjamin Stein","orcid":"https://orcid.org/0009-0007-9133-168X","observed_orcids":["https://orcid.org/0009-0007-9133-168X"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]},{"id":"https://openalex.org/I4405265386","display_name":"MiNK Therapeutics (United States)","ror":"https://ror.org/04n7wdr86","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265386"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert B Stein","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA","MiNK Therapeutics, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]},{"raw_affiliation_string":"MiNK Therapeutics, Lexington, MA, USA","institution_ids":["https://openalex.org/I4405265386"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080150466","display_name":"Dhan Sidhartha Chand","orcid":"https://orcid.org/0009-0003-8124-4399","observed_orcids":["https://orcid.org/0009-0003-8124-4399"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dhan Chand","raw_affiliation_strings":["Agenus Inc., Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A304","last_page":"A304"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.07699999958276749,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colorectal-liver-metastases","display_name":"colorectal liver metastases","score":0.9629999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.8899999856948853},{"id":"https://openalex.org/keywords/botensilimab","display_name":"botensilimab","score":0.796999990940094},{"id":"https://openalex.org/keywords/balstilimab","display_name":"balstilimab","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ny-eso-1","display_name":"NY-ESO-1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/tcr-engineered-t-cells","display_name":"TCR-engineered T cells","score":0.8510000109672546},{"id":"https://openalex.org/keywords/organoid-models","display_name":"organoid models","score":0.6420000195503235},{"id":"https://openalex.org/keywords/kupffer-cells","display_name":"Kupffer cells","score":0.7250000238418579},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.6850000023841858},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.49799999594688416},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.8589000105857849},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7735000252723694},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7445999979972839},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5715000033378601},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5673999786376953},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4546999931335449},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3434000015258789},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32829999923706055},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3257000148296356},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29499998688697815},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2937999963760376},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.28619998693466187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2793000042438507},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2662000060081482}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0270","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A304.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0270","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0270","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A304.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225164722.pdf","grobid_xml":"https://content.openalex.org/works/W7225164722.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3211349770","https://openalex.org/W4415871257","https://openalex.org/W4365512214","https://openalex.org/W4393087584","https://openalex.org/W4414710012","https://openalex.org/W3212747176","https://openalex.org/W7225191939","https://openalex.org/W7225183276","https://openalex.org/W4412172640","https://openalex.org/W4404053080"],"abstract_inverted_index":{"Background":[0],"In":[1,289],"microsatellite-stable/mismatch":[2],"repair\u2013proficient":[3],"(MSS/pMMR)":[4],"colorectal":[5],"cancer":[6],"(CRC),":[7],"liver":[8,154,165,215,257,341,393,541,553],"metastases":[9,166,394],"create":[10],"a":[11,35,151,170,204,330,349,363],"uniquely":[12,71],"tolerogenic":[13],"immune":[14,25,31,86,370,409],"microenvironment":[15,328],"that":[16],"limits":[17],"T-cell":[18,104,241,296,534],"priming,":[19],"effector":[20,210,537],"function,":[21],"and":[22,50,60,84,98,114,129,136,145,184,193,223,233,248,263,266,295,304,308,315,356,387,536,545,550,571],"responsiveness":[23],"to":[24,73,159,203,207,367,416,442,522],"checkpoint":[26,410],"inhibitor":[27],"(ICI)":[28,412],"therapy.":[29],"This":[30],"resistance":[32,371,441],"likely":[33],"reflects":[34],"convergence":[36],"of":[37,46,52,103,107,111,118,127,213,238,255,268,313,325,354,383,428,465,500],"factors,":[38],"including":[39,101,259],"impaired":[40],"antigen":[41,281],"presentation,":[42],"loss":[43],"or":[44,116,230],"dysfunction":[45],"tumor-reactive":[47],"T":[48,67,198],"cells,":[49,113,192,228,562],"enrichment":[51,267],"immunosuppressive":[53],"myeloid":[54],"populations":[55],"such":[56],"as":[57],"Kupffer":[58,189],"cells":[59,69,180,200,284],"myeloid-derived":[61],"suppressor":[62],"cells.":[63,454],"Invariant":[64],"natural":[65,452],"killer":[66],"(iNKT)":[68],"are":[70],"positioned":[72],"address":[74,368],"these":[75,319],"barriers":[76],"by":[77,573],"combining":[78],"direct":[79],"cytotoxicity":[80],"with":[81,96,139,220,226,229,272,322,385,391,407,449,548,558,581],"broad":[82],"innate":[83],"adaptive":[85],"modulation.":[87],"AgenT-797":[88,134,221,291,337,384,401],"is":[89],"an":[90,141,147,345,475],"allogeneic,":[91],"off-the-shelf":[92],"iNKT":[93,477],"cell":[94,402,444,478],"therapy":[95,403,516],"tissue-homing":[97],"immune-reconditioning":[99],"properties,":[100],"enhancement":[102],"responsiveness,":[105],"recruitment":[106],"cytotoxic":[108,332],"lymphocytes,":[109],"activation":[110,294],"dendritic":[112],"depletion":[115],"repolarization":[117],"suppressive":[119,339],"M2-like":[120,269],"macrophages.":[121,270],"1\u20134":[122],"Given":[123],"the":[124,209,326,378,423,463,495,519],"complementary":[125,365],"mechanisms":[126],"iNKT-cell":[128],"ICI":[130,275],"therapy,":[131,479],"we":[132],"evaluated":[133],"alone":[135,222,276,544],"in":[137,150,224,372,389,484,539,546],"combination":[138,225,547],"botensilimab,":[140],"Fc-enhanced":[142],"anti-CTLA-4":[143],"antibody,":[144,149],"balstilimab,":[146],"anti-PD-1":[148],"human-relevant":[152],"CRC":[153,164,179,256,340,392,540,552],"metastasis":[155,342,542],"organoid":[156,174,177,300],"model":[157,208],"designed":[158],"recapitulate":[160],"ICI-refractory":[161,163],"disease.Methods":[162],"were":[167,201,218,556],"modeled":[168],"using":[169],"multicellular":[171],"ex":[172],"vivo":[173],"system.5":[175],"Each":[176],"integrated":[178],"co-expressing":[181],"nuclear":[182],"GFP":[183],"HLA-A2-restricted":[185],"NY-ESO-1,":[186],"primary":[187],"hepatocytes,":[188],"cell-enriched":[190],"non-parenchymal":[191],"HLA-matched":[194],"PBMCs.":[195],"NY-ESO-1-specific":[196],"TCR-engineered":[197],"(TCR-T)":[199],"titrated":[202],"suboptimal":[205],"dose":[206],"insufficiency":[211],"characteristic":[212],"MSS/pMMR":[214,373],"metastases.":[216],"Organoids":[217,251],"treated":[219,557],"TCR-T":[227,283,561],"without":[231],"botensilimab":[232,314,355,386,549],"balstilimab.":[234,551],"Readouts":[235],"included":[236],"quantification":[237],"immune-cell":[239],"infiltration,":[240],"activation,":[242],"cytokine":[243],"production,":[244,307],"granzyme":[245,305],"B":[246,306],"induction,":[247],"tumor-cell":[249,287,310],"killing.Results":[250],"recapitulated":[252],"key":[253],"features":[254],"metastases,":[258],"elevated":[260],"CXCL12,":[261],"FAP,":[262],"TGF-\u03b2":[264],"expression,":[265],"Consistent":[271],"clinical":[273,482],"experience,":[274],"showed":[277],"limited":[278,286],"activity.":[279],"Despite":[280],"specificity,":[282],"demonstrated":[285],"killing.":[288,311],"contrast,":[290],"enhanced":[292,359],"TCR-T-cell":[293],"infiltration":[297,535],"into":[298],"tumor-cell-containing":[299],"regions,":[301],"increased":[302],"IFN-\u03b3":[303,570],"augmented":[309],"Addition":[312,353],"balstilimab":[316,357,388],"further":[317,358],"amplified":[318],"effects,":[320],"consistent":[321],"cooperative":[323],"remodeling":[324],"tumor":[327,520],"toward":[329,348],"pro-inflammatory,":[331],"state":[333,347],"(":[334,395],"figure":[335],"1).Conclusions":[336],"reconditioned":[338],"organoids":[343,555],"from":[344],"immune-resistant":[346],"cytotoxic,":[350],"T-cell-permissive":[351],"microenvironment.":[352],"this":[360],"activity,":[361],"supporting":[362],"mechanistically":[364],"strategy":[366],"liver-associated":[369],"CRC.":[374],"These":[375],"findings":[376,490],"support":[377],"ongoing":[379],"Phase":[380,488],"2":[381],"evaluation":[382],"patients":[390],"NCT07550088).References":[396],"Popis":[397],"M,":[398,457],"et":[399,438,458,472,511],"al.":[400,439,459,473,512],"can":[404],"be":[405],"combined":[406],"next-generation":[408],"inhibitors":[411],"and/or":[413,563],"bi-specific":[414],"engagers":[415],"improve":[417],"anti-cancer":[418],"response.":[419],"Poster":[420,435,492,508],"presented":[421,493],"at":[422,494],"Annual":[424,496],"Society":[425,497],"for":[426,498],"Immunotherapy":[427,499],"Cancer":[429,501,526],"Congress,":[430,502],"Houston,":[431],"TX,":[432],"USA.":[433,506],"2024.":[434],"#753.Hadfield":[436],"MJ,":[437],"Overcoming":[440],"programmed":[443],"death":[445],"protein":[446],"(PD-1)":[447],"blockade":[448],"allogeneic":[450,476,514],"invariant":[451],"killer-T":[453],"Oncogene":[455],"2024;43:758\u2013762.Niedzielska":[456],"CAR-iNKT":[460],"cells:":[461],"redefining":[462],"frontiers":[464],"cellular":[466],"immunotherapy.":[467],"Front":[468],"Immunol.":[469],"2025;16:1625426.Garmezy":[470],"B,":[471],"AgenT-797,":[474],"demonstrates":[480],"durable":[481],"activity":[483],"solid":[485],"tumors:":[486],"Updated":[487],"I":[489],"(NCT05108623).":[491],"National":[503],"Harbor,":[504],"MD,":[505],"2025.":[507],"#1344.Chantzoura":[509],"E,":[510],"The":[513],"FAP-CAR-IL-15":[515],"MiNK-215":[517],"remodels":[518],"stroma":[521],"enhance":[523],"antitumor":[524],"immunity.":[525],"Immunol":[527],"Res.":[528],"2026;14:243\u2013260.Abstract":[529],"270":[530],"Figure":[531],"1AgenT-797":[532],"enhances":[533],"function":[538],"organoids,":[543],"met":[554],"agenT-797,":[559],"NY-ESO-1":[560],"BOT/BAL.":[564],"(A)":[565],"Representative":[566],"images;":[567],"(B-C)":[568],"Secreted":[569],"GZMB":[572],"Luminex.":[574],"Points":[575],"=":[576],"individual":[577],"organoids.":[578],"One-way":[579],"ANOVA":[580],"Tukey":[582],"test":[583]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}